SWAV - Why Sarepta Therapeutics Stock Is Rising Today | Benzinga
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stock is trading higher on Thursday after it was announced the company will be added to the S&P MidCap 400.
What Happened: Effective prior to the opening of trading on June 3, Sarepta Therapeutics will join the S&P MidCap 400, replacing Shockwave Medical (NASDAQ:SWAV).
Johnson & Johnson (NYSE:JNJ) is expected to acquire Shockwave Medical in a deal that is currently pending final closing conditions. Johnson and ...